Rituximab: Pharmacology, Clinical Uses and Health Effects
( Pharmacology - Research, Safety Testing and Regulation )
Publication series ：Pharmacology - Research, Safety Testing and Regulation
Author： Gerond V. Lake-Bakaar (Beth Israel Deaconess Medical Center Boston MA)
Publisher： Nova Science Publishers, Inc.
Publication year： 2012
E-ISBN: 9781622575473
Subject： R979.1 anti - tumor, anti - cancer drug
Keyword： Pharmacology
Language： ENG
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Description
Rituximab (MabThera(r), Rituxan(r)) is a chimaeric murine/human antibody targeted against the surface antigen CD20 that is expressed on normal and malignant human mature B cells, but not stem cells or plasma cells. It is potentially the proverbial magic bullet for diseases associated with B cell disorders as well as a probe for elucidating the role of B cells in health and disease. This book explores the full spectrum of activity of Rituximab in man.